The medical technology company Polarcool reports increased net sales during the fourth quarter compared with the same period the year before. The operating loss increased.Net sales rose 16.7 percent to SEK 0.7 million (0.6).Operating result was SEK -4.9 million (-2.9). Result after tax was SEK -4.9 million (-2.9). Earnings per share amounted to SEK 0.88 (0.00). Cash and cash equivalents amounted to SEK 1.4 million (7.4)."Ongoing marketing efforts, in combination with a gradually growing customer base and increased awareness of Polarcap, constitute important building blocks for achieving this goal. In parallel with this, preparations ahead of the launch in the USA and Canada are intensifying. With access to new financing, the company assesses that the conditions are favorable to be ready for a market launch during the first half of 2026, provided that the necessary regulatory approvals are obtained in each respective country. North America represents a highly attractive market with great commercial potential and high receptivity to new medical device innovation. The ambition is for this market to contribute significantly to Polarcool’s total sales at an early stage", the company writes. Polarcool, SEK mQ4-2025Q4-2024ChangeNet sales0.70.616.7%Operating result-4.9-2.9Result before tax-4.9-2.9Net result-4.9-2.9Earnings per share, SEK0.880.00Cash and cash equivalents1.47.4-81.1%